Keyphrases
Hepatocellular Carcinoma
100%
Risk Reduction
100%
Antiretroviral Therapy
100%
Hepatocellular Carcinoma Risk
100%
Hepatitis C Virus Cirrhosis
100%
Confidence Interval
80%
Interferon-α (IFN-α)
60%
Risk Ratio
60%
Sustained Virological Response
60%
Meta-analysis
40%
Non-responders
40%
Ribavirin
40%
Initial Treatment
20%
Hepatitis C Virus
20%
Maximum Benefit
20%
Treatment Group
20%
Regression Analysis
20%
Maintenance Therapy
20%
Untreated Patients
20%
Response Rate
20%
Antiviral Treatment
20%
Systematic Meta-analysis
20%
Video Abstract
20%
Follow-up Interval
20%
Group Risk
20%
Random Effects Model
20%
Publication Bias
20%
Egger's Test
20%
Nursing and Health Professions
Liver Cell Carcinoma
100%
Liver Cirrhosis
100%
Hepatitis C
100%
Antiviral Therapy
100%
Confidence Interval
50%
Interferon
37%
Sustained Virologic Response
37%
Meta Analysis
25%
Ribavirin
25%
Hospital Service
12%
Effect Size
12%
Group Therapy
12%
Systematic Review
12%
Maintenance Therapy
12%
High Risk Population
12%
Medicine and Dentistry
Hepatocellular Carcinoma
100%
Hepatitis C Virus
100%
Liver Cirrhosis
100%
Antiviral Therapy
100%
Interferon
37%
Ribavirin
25%
Meta-Analysis
25%
Risk Reduction
25%
Group Therapy
12%
Effect Size
12%
Systematic Review
12%
High Risk Population
12%
Meta-Regression
12%
Random Effects Model
12%
Maintenance Therapy
12%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Liver Cirrhosis
100%
Antiviral Therapy
100%
Hepatitis C Virus
100%
Interferon
37%
Ribavirin
25%
Antivirus Agent
12%
Random Effects Model
12%